FI850654A0 - Menetelmä terapeuttisesti käyttökelpoisten pleuromutilinijohdannaisten valmistamiseksi - Google Patents

Menetelmä terapeuttisesti käyttökelpoisten pleuromutilinijohdannaisten valmistamiseksi

Info

Publication number
FI850654A0
FI850654A0 FI850654A FI850654A FI850654A0 FI 850654 A0 FI850654 A0 FI 850654A0 FI 850654 A FI850654 A FI 850654A FI 850654 A FI850654 A FI 850654A FI 850654 A0 FI850654 A0 FI 850654A0
Authority
FI
Finland
Prior art keywords
preparation
therapeutically useful
pleuromutilin derivatives
pleuromutilin
derivatives
Prior art date
Application number
FI850654A
Other languages
English (en)
Swedish (sv)
Other versions
FI90414C (fi
FI90414B (fi
FI850654L (fi
Inventor
Heinz Berner
Hermann Vyplel
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19843405632 external-priority patent/DE3405632A1/de
Priority claimed from DE19843413708 external-priority patent/DE3413708A1/de
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of FI850654A0 publication Critical patent/FI850654A0/fi
Publication of FI850654L publication Critical patent/FI850654L/fi
Priority to FI921848A priority Critical patent/FI88714C/fi
Application granted granted Critical
Publication of FI90414B publication Critical patent/FI90414B/fi
Publication of FI90414C publication Critical patent/FI90414C/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/51Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/57Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C323/58Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups with amino groups bound to the carbon skeleton
    • C07C323/59Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups with amino groups bound to the carbon skeleton with acylated amino groups bound to the carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/04Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D277/06Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
FI850654A 1984-02-17 1985-02-15 Menetelmä terapeuttisesti käyttökelpoisten pleuromutilinijohdannaisten valmistamiseksi FI90414C (fi)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FI921848A FI88714C (fi) 1984-02-17 1992-04-24 Pleuromutilinderivat befraemjande tillvaext

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE19843405632 DE3405632A1 (de) 1984-02-17 1984-02-17 Neue pleuromutilinderivate, verfahren zu ihrer herstellung und ihre verwendung
DE3405632 1984-02-17
DE3413708 1984-04-12
DE19843413708 DE3413708A1 (de) 1984-04-12 1984-04-12 Neue pleuromutilinderivate, verfahren zu ihrer herstellung und ihre verwendung

Publications (4)

Publication Number Publication Date
FI850654A0 true FI850654A0 (fi) 1985-02-15
FI850654L FI850654L (fi) 1985-08-18
FI90414B FI90414B (fi) 1993-10-29
FI90414C FI90414C (fi) 1994-02-10

Family

ID=25818547

Family Applications (1)

Application Number Title Priority Date Filing Date
FI850654A FI90414C (fi) 1984-02-17 1985-02-15 Menetelmä terapeuttisesti käyttökelpoisten pleuromutilinijohdannaisten valmistamiseksi

Country Status (21)

Country Link
US (1) US4675330A (fi)
EP (1) EP0153277B1 (fi)
JP (1) JPH068278B2 (fi)
KR (1) KR920001990B1 (fi)
AU (1) AU585209B2 (fi)
CA (1) CA1249281A (fi)
CY (1) CY1565A (fi)
DE (1) DE3560511D1 (fi)
DK (1) DK164664C (fi)
ES (1) ES8606262A1 (fi)
FI (1) FI90414C (fi)
GR (1) GR850415B (fi)
HK (1) HK103690A (fi)
HU (1) HU194819B (fi)
IE (1) IE58232B1 (fi)
IL (1) IL74355A (fi)
MY (1) MY102919A (fi)
NZ (1) NZ211131A (fi)
PH (1) PH21588A (fi)
PL (1) PL145848B1 (fi)
SG (1) SG69290G (fi)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT392272B (de) * 1989-10-03 1991-02-25 Biochemie Gmbh Verfahren zur herstellung eines pleuromutilinderivats und seiner saeureadditionssalze
HU208115B (en) * 1989-10-03 1993-08-30 Biochemie Gmbh New process for producting pleuromutilin derivatives
AT400674B (de) * 1991-07-24 1996-02-26 Biochemie Gmbh Pharmazeutische pleuromutilin-zubereitung
AT397654B (de) * 1992-05-04 1994-06-27 Biochemie Gmbh Neue pleuromutilinderivate, ihre verwendung und verfahren zu ihrer herstellung
KR100516418B1 (ko) * 1996-07-04 2005-12-20 바이오케미 게젤샤프트 엠베하 플루로뮤틸린유도체의수의학적용도
GB9614017D0 (en) * 1996-07-04 1996-09-04 Biochemie Gmbh Organic compounds
NO331772B1 (no) * 1996-07-04 2012-03-26 Biochemie Gmbh Veterinaermedisinsk anvendelse av et pleuromutilinderivat
UY25225A1 (es) 1997-10-29 2000-12-29 Smithkline Beecham Plc Derivados de pleuromutilina utiles como agentes antimicrobianos
GB9918037D0 (en) * 1999-07-30 1999-09-29 Biochemie Gmbh Organic compounds
TWI260220B (en) * 1999-11-22 2006-08-21 Novartis Ag A pharmaceutical composition for the transdermal treatment of bacterial infections in animals
GB0017031D0 (en) * 2000-07-11 2000-08-30 Biochemie Gmbh Antimicrobials
PE20020676A1 (es) * 2000-09-13 2002-08-27 Biochemie Gmbh Compuestos de mutilina como antibacterianos
CO5390081A1 (es) 2001-11-28 2004-04-30 Novartis Ag Compuestos organicos
US20040116510A1 (en) * 2002-03-05 2004-06-17 Nichtberger Steven A. Antihypertensive agent and cholesterol absorption inhibitor combination therapy
GB0209262D0 (en) * 2002-04-23 2002-06-05 Biochemie Gmbh Organic compounds
GB0308114D0 (en) * 2003-04-08 2003-05-14 Glaxo Group Ltd Novel compounds
EP1686115A1 (de) * 2005-01-26 2006-08-02 Novartis AG Organische Säureadditionssalze von Valnemulin
GB0504314D0 (en) * 2005-03-02 2005-04-06 Glaxo Group Ltd Novel polymorph
CN101880252B (zh) * 2010-06-29 2013-01-23 金河生物科技股份有限公司 盐酸沃尼妙林的制备方法
CN102229580B (zh) * 2011-05-12 2014-02-26 南通大学 新型截短侧耳素衍生物、其制备方法及其医药用途
CN102344397B (zh) * 2011-08-23 2013-09-04 浙江升华拜克生物股份有限公司 一种伐奈莫林盐酸盐的提纯方法
CN102424660B (zh) * 2011-08-25 2013-11-27 浙江升华拜克生物股份有限公司 一种伐奈莫林盐酸盐的低温起泡干燥法及其干燥品
CN102675173B (zh) * 2012-04-28 2013-12-11 武汉回盛生物科技有限公司 一种盐酸沃尼妙林的化学合成方法
CN103193692A (zh) * 2013-04-23 2013-07-10 河北科技大学 一种沃尼妙林及其盐酸盐的制备
CN104311464A (zh) * 2014-09-15 2015-01-28 河北威远动物药业有限公司 一种兽用沃尼妙林的制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4060542A (en) * 1969-07-25 1977-11-29 Biochemie Gesellschaft M.B.H. 14-Desoxy-14 thiocyanato-acetoxy-mutilin
US3919290A (en) * 1972-10-03 1975-11-11 Sandoz Ltd Substituted 14-desoxy-mutilins
US4086359A (en) * 1975-09-30 1978-04-25 E. R. Squibb & Sons, Inc. Derivatives of pleuromutilin and compositions
CH619450A5 (fi) * 1976-01-15 1980-09-30 Sandoz Ag
JPS54160358A (en) * 1978-06-06 1979-12-19 Sandoz Ag Improvement for organic compound
GB2072012B (en) * 1980-03-14 1984-07-25 Squibb & Sons Inc Veterinary compositions containing pleuromutilin derivatives
FR2526019A1 (fr) * 1982-04-28 1983-11-04 Sandoz Sa Nouveaux derives de la pleuromutiline, leur preparation et leur utilisation comme medicaments

Also Published As

Publication number Publication date
IL74355A0 (en) 1985-05-31
HUT39155A (en) 1986-08-28
DK72885D0 (da) 1985-02-15
EP0153277B1 (de) 1987-08-26
IL74355A (en) 1988-04-29
PL145848B1 (en) 1988-11-30
MY102919A (en) 1993-03-31
CA1249281A (en) 1989-01-24
ES8606262A1 (es) 1986-04-16
IE850375L (en) 1985-08-17
HK103690A (en) 1990-12-21
PL251972A1 (en) 1985-12-03
US4675330A (en) 1987-06-23
KR920001990B1 (ko) 1992-03-09
EP0153277A2 (de) 1985-08-28
NZ211131A (en) 1988-08-30
FI90414C (fi) 1994-02-10
FI90414B (fi) 1993-10-29
GR850415B (fi) 1985-06-18
PH21588A (en) 1987-12-11
DK164664C (da) 1992-12-21
JPS60199870A (ja) 1985-10-09
ES540464A0 (es) 1986-04-16
JPH068278B2 (ja) 1994-02-02
FI850654L (fi) 1985-08-18
KR850006938A (ko) 1985-10-25
DE3560511D1 (en) 1987-10-01
IE58232B1 (en) 1993-08-11
DK72885A (da) 1985-08-18
DK164664B (da) 1992-07-27
EP0153277A3 (en) 1985-09-25
AU3877385A (en) 1985-09-12
SG69290G (en) 1990-11-23
CY1565A (en) 1991-05-17
AU585209B2 (en) 1989-06-15
HU194819B (en) 1988-03-28

Similar Documents

Publication Publication Date Title
FI850654A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten pleuromutilinijohdannaisten valmistamiseksi
FI883064A (fi) Menetelmä terapeuttisesti käyttökelpoisten heterosyklisten yhdisteiden valmistamiseksi
FI92934B (fi) Analogiamenetelmä terapeuttisesti käyttökelpoisten 1-deoksinojirimysiinijohdannaisten valmistamiseksi
FI880941A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten piperatsinyyli-heterosyklisten yhdisteiden valmistamiseksi
FI882007A (fi) Menetelmä steroidi-5- -reduktaasin inhibiittorien valmistamiseksi
FI890282A (fi) Menetelmä terapeuttisesti käyttökelpoisten 23,24-didehydro-25-hydroksikalsiferolijohdannaisten valmistamiseksi
FI90769C (fi) Menetelmä terapeuttisesti käyttökelpoisten triatsoliyhdisteiden valmistamiseksi
FI874459A0 (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten piperidiinijohdannaisten valmistamiseksi
FI94752C (fi) Menetelmä terapeuttisesti käyttökelpoisten propenonioksiimieettereiden valmistamiseksi
FI93215C (fi) Menetelmä terapeuttisesti käyttökelpoisten aminoalkoksifenyylijohdannaisten valmistamiseksi
FI880467A (fi) Menetelmä terapeuttisesti käyttökelpoisten substituoitujen 3,4-dihydro-2H-bentsopyraanien valmistamiseksi
FI884910A (fi) Menetelmä terapeuttisesti käyttökelpoisten bentsopyraanijohdannaisten valmistamiseksi
FI884471A0 (fi) Menetelmä terapeuttisesti aktiivisten dihydropyridiinijohdannaisten valmistamiseksi
FI104075B1 (fi) Menetelmä terapeuttisesti käyttökelpoisten 2-karboksitienyylikarbamoyylipyrrolidin-4-yylitiokarbapeneemi-3-karboksyylihappojohdannaisten valmistamiseksi
FI893936A (fi) Menetelmä terapeuttisesti aktiivisten yhdisteiden valmistamiseksi sekä välituotteita
FI893003A0 (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten neplanosiinijohdannaisten valmistamiseksi
FI903077A0 (fi) Menetelmä valmistaa terapeuttisesti aktiivisia R(-)-3-kinuklidinolijohdannaisia
FI92188C (fi) Menetelmä terapeuttisesti käyttökelpoisten fenoksialkyylipyrokatekolijohdannaisten valmistamiseksi
FI880190A0 (fi) Menetelmä valmistaa terapeuttisesti vaikuttavia tetrahydrofuraanijohdoksia
FI911701A (fi) Menetelmä terapeuttisesti käyttökelpoisten 2-substituoitujen alkyyli-3-karboksikarbapeneemien valmistamiseksi
FI89062C (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara somatostatinanaloger
FI863471A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten 3-desmetyylimevalonihappojohdannaisten valmistamiseksi
FI840481A0 (fi) Foerfarande och anordning foer tagande av producentvist mjoelkprov
FI893434A0 (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten sykloalkyylitiatsolijohdannaisten valmistamiseksi
FI892144A0 (fi) Menetelmä 5-C-hydroksimetyylialdoheksoosipohjaisten yhdisteiden valmistamiseksi

Legal Events

Date Code Title Description
BB Publication of examined application
PC Transfer of assignment of patent

Owner name: NOVARTIS AG

FG Patent granted

Owner name: NOVARTIS AG

MA Patent expired